1. Home
  2. SINT vs PRFX Comparison

SINT vs PRFX Comparison

Compare SINT & PRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SiNtx Technologies Inc.

SINT

SiNtx Technologies Inc.

HOLD

Current Price

$3.65

Market Cap

15.0M

Sector

Health Care

ML Signal

HOLD

Logo PainReform Ltd.

PRFX

PainReform Ltd.

HOLD

Current Price

$0.94

Market Cap

1.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SINT
PRFX
Founded
1996
2007
Country
United States
Israel
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.0M
1.8M
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
SINT
PRFX
Price
$3.65
$0.94
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$16.00
N/A
AVG Volume (30 Days)
88.8K
141.7K
Earning Date
11-13-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,270,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$80.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.71
$0.80
52 Week High
$7.36
$16.63

Technical Indicators

Market Signals
Indicator
SINT
PRFX
Relative Strength Index (RSI) 49.33 47.72
Support Level $3.30 $0.90
Resistance Level $4.46 $1.09
Average True Range (ATR) 0.36 0.09
MACD 0.03 0.02
Stochastic Oscillator 38.89 36.46

Price Performance

Historical Comparison
SINT
PRFX

About SINT SiNtx Technologies Inc.

SINTX Technologies Inc is a ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming a renowed ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have good bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.

About PRFX PainReform Ltd.

PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.

Share on Social Networks: